GSK plc (GSK) vs Stryker Corporation (SYK)
GSK leads on 14 of 17 compared metrics.
A side-by-side comparison of GSK plc and Stryker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — GSK vs SYK
growth of $100 · last 30yGSK +98.1%SYK +5686.3%SYK compounded faster
Log scale — wide-divergence pair
GSK SYK
GSK vs SYK: by the numbers
- •SYK is the larger company ($127.39B vs $105.20B market cap).
- •GSK trades at the lower earnings multiple (11.62 vs 38.51 P/E).
- •GSK converts more revenue to profit (17.76% vs 13.21% net margin).
- •SYK grew revenue faster over the past five years (11.42% vs 0.63% CAGR).
- •GSK pays the higher dividend yield (3.51% vs 1.06%).
Which is better, GSK or SYK?
Metric tally: GSK 14 · SYK 3It depends on what you're optimizing for:
ValueGSK(lower P/E)
GrowthSYK(faster 5Y revenue CAGR)
IncomeGSK(higher dividend yield)
QualityGSK(higher ROIC)
Metrics side by side
Valuation
| Metric | GSK | SYK |
|---|---|---|
| P/E ratio | 11.62● | 38.51 |
| Forward P/E | 13.25● | 19.88 |
| P/S ratio | 2.42● | 5.09 |
| P/B ratio | 3.44● | 5.60 |
| PEG ratio | 0.02● | 5.16 |
| EV / EBITDA | 8.62● | 21.23 |
| FCF yield | 7.87%● | 3.55% |
Profitability
| Metric | GSK | SYK |
|---|---|---|
| Gross margin | 72.67%● | 63.67% |
| Operating margin | 25.65%● | 21.34% |
| Net margin | 17.76%● | 13.21% |
| ROE | 25.19%● | 14.52% |
| ROIC | 16.61%● | 8.53% |
Dividends
| Metric | GSK | SYK |
|---|---|---|
| Dividend yield | 3.51%● | 1.06% |
| Payout ratio | 24.30% | 41.46% |
Growth (annualized)
| Metric | GSK | SYK |
|---|---|---|
| Revenue CAGR (5Y) | 0.63% | 11.42%● |
| EPS CAGR (5Y) | 14.05% | 14.79%● |
| FCF CAGR (5Y) | -0.35% | 11.01%● |
| Total return CAGR (5Y) | 10.18%● | 5.89% |
Frequently asked
- Which is better, GSK or SYK?
- It depends on your goal. value: GSK (lower P/E); growth: SYK (faster 5Y revenue CAGR); income: GSK (higher dividend yield); quality: GSK (higher ROIC). Across all compared metrics, GSK leads 14 to 3.
- Is GSK or SYK cheaper?
- On trailing earnings, GSK is cheaper: GSK trades at a 11.62 P/E and SYK at 38.51.
- Which has grown faster, GSK or SYK?
- Over the past five years, SYK grew revenue faster — GSK at a 0.63% CAGR versus SYK at 11.42%.
- Does GSK or SYK pay a bigger dividend?
- GSK yields 3.51% and SYK yields 1.06% based on trailing dividends and the latest price.
- Is GSK or SYK more profitable?
- GSK runs the higher net margin — GSK at 17.76% versus SYK at 13.21%.
- Which has been the better investment, GSK or SYK?
- Over the past 10-year, SYK delivered the higher annualized total return — GSK at 7.50% versus SYK at 12.29%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
GSK P/E ratioStryker P/E ratioGSK dividend yieldStryker dividend yieldGSK ROEStryker ROEGSK operating marginStryker operating marginGSK revenue growthStryker revenue growthGSK free cash flowStryker free cash flow
GSK & Stryker appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.